Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.

Patients warned not to turn to fake weight loss jabs after UK Mounjaro price hike - Pharmacists fear rise in sale of dangerous counterfeit medicines as drugmaker triples price of prescription ...

A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following ...